top of page

Meet the leadership

We exist to accelerate clinical trials & help patients access tomorrow's medicines today

Screenshot%202020-09-17%20at%2009.10_edi

Dr Radoslaw Janiak

Chief Executive Officer

  • LinkedIn

Radoslaw studied medicine at the University of Warsaw graduating in 1997. After working as a hospital doctor for 4 years he moved into clinical research initially as a site director for a Polish CRO.  Working for Synexus from 2005 until 2019 he was responsible for the rapid growth of the business across Central and Eastern Europe.

Screenshot 2024-03-12 at 12.45.07.png

Paul Chambers

Chairman

  • LinkedIn

Paul graduated from the University of Sheffield before training as a Chartered Accountant with KPMG.  He spent five years in Practice before moving into industry.  Formerly CFO of Synexus from 2010-2017, leading the business through a period of substantial growth culminating in two successful private equity exits.

Screenshot 2024-03-12 at 12.44.54.png

Marcin Gondek

Chief Financial Officer

  • LinkedIn

Marcin is a graduate in Economics from the University of Wroclaw.  He spent 10 years working in senior finance roles for a number of multinational companies.  He joined Synexus in 2012, initially as finance director for Central and Eastern Europe and has extensive knowledge of site operations, feasibility and contracting.

torsten_futuremeds_edited.jpg

Dr Torsten Sernau

VP of Medical Operations

  • LinkedIn

With a successful track record spanning 28 years in the clinical research industry, Dr Torsten Sernau is responsible for nurturing relations with key Pharmaceutical clients, strategising our offerings across all therapeutic areas and enhancing the visibility of FutureMeds in the industry. 

Screenshot 2024-04-03 at 13.05.02.png

Nicole Bohrmann

Director of Decentralized Operations

  • LinkedIn

Chris graduated from the University of Kent with a degree in Mathematics.  He has spent 35 years in the clinical trials industry having held senior positions at Roche, P&G, Covance and Kendle (now part of Syneos), where he served as UK Managing Director.  Chris joined Synexus in 2007 and ultimately held the role of Chief Commercial Officer until his retirement in 2016.

LL7A5354_p_1pp_edited.jpg

Prof. Edward Czerwinski

Senior Medical Director

  • LinkedIn

Edward is a Professor of the Jagiellonian University with 45+ years of experience as a practicing orthopaedic surgeon in addition to being an active university lecturer and scientist.  He founded the Krakow Medical Centre (KCM) in 1996 and has supervised over 200 trials acting as PI on 49. Edward serves on multiple scientific boards and has organised several international congresses, including the World Congress on Osteoporosis in 2018. 

ivan.jpeg

Ivan Vyshnyvetskyy MD Ph.D.

Managing Director, Ukraine

  • LinkedIn

Ivan has over 20 years of experience in medical practice and clinical research. He is an Investigator with 50+ clinical trials experience, including 30+ trials as a PI and is the President of the Ukrainian Association for Clinical Research, which under his governance became the largest and most influential Ukrainian professional society in the field.

Borislav-B.png

Borislav Borissov MD MBA, DSc

Managing Director, Bulgaria

  • LinkedIn

Prof. Dr. Borislav Borissov, MD, MBA, DSc, with over 31 years of medical and over 11 years of clinical trials management experience, will be responsible for leading FutureMeds’ Bulgarian operations and extending FutureMeds' network of medical research clinics into Bulgaria.

piotr.jpeg

Dr. Piotr Rozpondek MD PhD

Managing Director, Poland

  • LinkedIn

As Managing Director of FutureMeds Poland, Piotr aims to further improve access for patients to clinical trials using virtual visits and home nursing, advance decentralized clinical trials processes, start hospital-based new sites, and introduce oncology studies to FutureMeds’ therapeutic areas.

iwona.jpeg

Iwona Tongbhoyai

Chief Client Solutions Officer

  • LinkedIn

With over 12 years Sites and Clinical Trials Management experience and over 7 years Business Consultancy experience, Iwona Tongbhoyai will play a key role in increasing FutureMeds’ operational efficiency and strengthening the FutureMeds brand by providing successful and effective solutions to clients, partners and patients alike.

Cameron-G.png

Cameron Glen

VP of Global Business Development

  • LinkedIn

Cameron has a unique blend of industry experience and knowledge. He spent 23 years of his career building & forging alliances and pursuing new business for notable public and private sector players such as Menarini Pharmaceuticals, AstraZeneca, University of Dundee/NHS Tayside, Synexus, and industry-leading CROs such as Covance Inc. (Labcorp R&D) and ICON plc.

Grzegorz-K.png

Grzegorz Krówczyński

VP of IT

  • LinkedIn

With over 17 years of professional experience and deep domain knowledge of Business Intelligence, Data Management and Clinical Trial Management Systems, Grzegorz plays a key role in building FutureMeds' IT arm and ensuring that the company is fully prepared and ready for driving innovations in the Clinical Trials market.

1622799432119 (1).jpeg

John Allen

Managing Director, UK

  • LinkedIn

With over 15 years clinical research experience and a background as a qualified accountant, John brings a unique blend of expertise to our team. His commitment to high patient recruitment have been pivotal in establishing multiple sites for FutureMeds UK.  John Allen leadership and extensive knowledge are instrumental in making a positive impact in UK clinical research.

Foto_Rocio_Diaz.jpeg

Rocio Diaz Sanchez

Managing Director, Spain

  • LinkedIn

With over 12 years of experience in Research Management in different academic institutions and private hospitals, Rocio Diaz, in her role of Managing Director of FutureMeds Spain aims to bring the patients’ the best treatment. Through her continued commitment to excellence, Rocio strives to contribute further to the betterment of society.

1682583737982.jpeg

Dr. med. Bettina Bergtholdt

Managing Director, Germany

  • LinkedIn

After finalizing her studies of human medicine at the Free University of Berlin, Bettina worked for several years in different psychiatric departments as junior physician. She came first in contact with clinical research in 1999, while building up an outpatient clinic for a research project in suicide prevention. In 2001 she founded her own business emovis GmbH, starting with a dedicated research site for pharmaceutical studies. A sleep lab, exclusively for clinical research projects, followed in 2008 and 2012 the department “Homecare Visits” completed the services. In 2023 Bettina joined forces with FutureMeds, becoming Managing Director of Germany.

1660731281448.jpeg

Director of Global Feasibility and Proposals

  • LinkedIn

With over 15 years clinical research experience and a background as a qualified accountant, John brings a unique blend of expertise to our team. His commitment to high patient recruitment have been pivotal in establishing multiple sites for FutureMeds UK.  John Allen leadership and extensive knowledge are instrumental in making a positive impact in UK clinical research.

1595236592859.jpeg

Nachiket Chandak

Senior Director Business Development

  • LinkedIn

With over 12 years of experience in Research Management in different academic institutions and private hospitals, Rocio Diaz, in her role of Managing Director of FutureMeds Spain aims to bring the patients’ the best treatment. Through her continued commitment to excellence, Rocio strives to contribute further to the betterment of society.

1635179848592.jpeg

Wojciech Szczepanik

Managing Director, Germany

  • LinkedIn

After finalizing her studies of human medicine at the Free University of Berlin, Bettina worked for several years in different psychiatric departments as junior physician. She came first in contact with clinical research in 1999, while building up an outpatient clinic for a research project in suicide prevention. In 2001 she founded her own business emovis GmbH, starting with a dedicated research site for pharmaceutical studies. A sleep lab, exclusively for clinical research projects, followed in 2008 and 2012 the department “Homecare Visits” completed the services. In 2023 Bettina joined forces with FutureMeds, becoming Managing Director of Germany.

bottom of page